Iovance Biotherapeutics Inc
(IOVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -16 | -57 | -2 | N/A |
| Depreciation Amortization | 1 | 1 | 0 | N/A |
| Other Working Capital | 0 | -4 | 5 | N/A |
| Other Operating Activity | 15 | 0 | 0 | 0 |
| Operating Cash Flow | $0 | $-60 | $3 | $N/A |
| Cash Flows From Investing Activities | ||||
| Purchase Sale Intangibles | N/A | N/A | -4 | N/A |
| Other Investing Activity | 0 | 0 | -4 | 0 |
| Investing Cash Flow | $N/A | $N/A | $-4 | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | N/A | N/A | 61 | N/A |
| Other Financing Activity | 20 | 3 | 0 | 0 |
| Financing Cash Flow | $20 | $3 | $61 | $N/A |
| Beginning Cash Position | 3 | 60 | 0 | N/A |
| End Cash Position | 8 | 3 | 60 | N/A |
| Net Cash Flow | $5 | $-57 | $60 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | 0 | -60 | 3 | N/A |
| Free Cash Flow | 0 | -60 | 3 | 0 |